This course was designed to address the rapidly evolving landscape of headache medicine, focusing on the “paradigm shift” from acute symptom management to a comprehensive understanding of migraine as a complex brain disease. The program highlighted the latest advancements in diagnosis and therapeutics, specifically the integration of new pharmacological agents (CGRP inhibitors) and the management of secondary and rare headache disorders. It provided a unique forum for clinicians to explore “fluff-free,” clinically relevant strategies for patients who do not respond to standard protocols.
+ What You Will Learn
Attendees were able to:
Identify and manage rare primary headache disorders and indomethacin-responsive headache syndromes.
Evaluate the connection between systemic conditions and migraine, specifically the roles of Mast Cells, Ehlers-Danlos Syndrome (EDS), and Dysautonomia.
Analyze the latest research regarding migraine as a risk factor for dementia and the brain-gut connection.
Apply new treatment paradigms involving CGRP monoclonal antibodies and other novel therapeutics to optimize patient outcomes.
Diagnose secondary headaches effectively, including post-traumatic headache and headache manifestations involving the eye.
Develop strategies for “unique patient encounters,” enhancing wellness and managing “special patients” (e.g., those with complex comorbidities or psychological factors).
+ Event Details
Date: July 13 – 15, 2023
Location: Disney’s Grand Floridian Resort & Spa, Lake Buena Vista, Florida
Format: Live In-Person Conference
Organizer: Diamond Headache Clinic Research & Educational Foundation
+ Who Should Attend
The conference was targeted at the interdisciplinary team involved in headache care:
Neurologists and Headache Specialists
Primary Care Physicians (Internal Medicine, Family Practice)
Advanced Practice Providers (Nurse Practitioners, Physician Assistants)
Nurses
Ophthalmologists (given the specific sessions on “Headache and the Eye”)
Pain Management Specialists
+ Why Attend
Cutting-Edge Curriculum: The 2023 agenda featured specialized topics often overlooked in general neurology courses, such as the link between dysautonomia/EDS and migraine (“The Triad”).
Expert Faculty: The event hosted world-renowned experts, including Dr. Peter J. Goadsby, Dr. Merle L. Diamond, and Dr. Mark W. Green, providing direct access to the leaders shaping the future of headache medicine.
Clinical Focus: The sessions were structured to provide actionable “pearls” for difficult management issues, moving beyond theory to address how to treat the “intractable” patient sitting in the exam room.
+ Topics:
Migraine as a Risk Factor for Dementia
Brain Gut Connection
Headache and the Eye
A Case-Based Approach to Understanding CSF Pressure Disorders & Orthostatic Headaches
Cluster Headache
Thunderclap Headache
Tension, High & Low Pressure & Cervicogenic Headaches
Disparities in Migraine Care
Sleep Disorders in Migraine
Chronic Analgesics, Comorbid Pain Disorders, and Medication Overuse Headache
Multidisciplinary Approach To Intractable Headache Patient
Psychiatric Comorbidities & Migraine
BMI Comorbidity Related to Therapies
Concussion & Post-Concussion Headache In Children & Adolescents
Migraine & Pregnancy
Epidemiology & Disease Burden
Pathophysiology & CGRP – A New Era in Migraine
HCP-Patient Dialogue – From Then to Now: Raising the Bar in Patient Care
Pre-Headache & Migraine Freedom
Acute Treatments Every Patient Should Have in Their Toolbox
Prevention – How to Decide & Pharmacological Targets
CGRP & the New Treatment Paradigm
Optimization of Diagnosis & Treatment
Unique Patient Encounters – How to Enhance Patient Wellness
How to Deal with Special Patients
Secondary Headaches
Rare Primary Headache Disorders
Mast Cells, EDS, Dysautonomia & Migraine
Indomethacin Responsive Headache Syndromes
Intractable Headaches & Difficult Management Issues
Interactive Q&A Sessions





Reviews
There are no reviews yet.